Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. 더 보기
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio PR Newswire ST. PAUL, Minn., Jan. 21, 2025 ST. PAUL, Minn., Jan. 21, 2025 /PRNewswire/ -- ScaleReady, in collaboration with...
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire MINNEAPOLIS, Jan. 10, 2025 MINNEAPOLIS, Jan. 10, 2025...
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire ST. PAUL, Minn., Jan. 8, 2025 ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in...
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire MINNEAPOLIS, Jan. 7, 2025 MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...
ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.57 | 3.37536117678 | 76.14 | 79.7 | 73.67 | 912681 | 76.47284228 | CS |
4 | 6.3 | 8.70045573816 | 72.41 | 79.7 | 70.755 | 745707 | 74.81099388 | CS |
12 | 4.71 | 6.36486486486 | 74 | 80.8 | 65.61 | 903963 | 73.61906541 | CS |
26 | 2.36 | 3.09102815979 | 76.35 | 83.62 | 65.61 | 893946 | 74.19915377 | CS |
52 | 7.77 | 10.9529179588 | 70.94 | 85.57 | 61.16 | 969325 | 73.39281185 | CS |
156 | -12.51 | -13.7140977856 | 91.22 | 113.805 | 51.79 | 782982 | 75.8145937 | CS |
260 | 23.1375 | 41.6348013856 | 55.5725 | 135.9625 | 38.7925 | 557382 | 78.05681528 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관